Viewing Study NCT04028492

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2026-01-22 @ 9:30 AM
Study NCT ID: NCT04028492
Status: COMPLETED
Last Update Posted: 2025-07-24
First Post: 2019-07-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
Sponsor: Vanda Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Idiopathic Gastroparesis View
None Diabetic Gastroparesis View
None Gastroparesis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None gastroparesis View
None idiopathic View
None diabetic View
None tradipitant View
None nausea View
None vomiting View
None stomach View
None motility View
None functional View
None NK-1 antagonist View
None neurokinin 1 receptor View
None substance p View